SERPINA4 and chronic obstructive pulmonary disease: To our knowledge, only Ngo et al. [13] have investigated kallistatin in COPD, associating it with FEV1 and FEV1/FVC across six heterogeneous cohorts but limited by prebronchodilator measures and assay variability.